Related references
Note: Only part of the references are listed.Analysis of microRNAs in Exosomes of Breast Cancer Patients in Search of Molecular Prognostic Factors in Brain Metastases
Carolin J. Curtaz et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Prognostic and Predictive Effects of Tumor and Plasma miR-200c-3p in Locally Advanced and Metastatic Breast Cancer
Esther Navarro-Manzano et al.
CANCERS (2022)
Hepatocellular carcinoma risk-stratification based on ASGR1 in circulating epithelial cells for cancer interception
Amparo Roa-Colomo et al.
FRONTIERS IN MOLECULAR BIOSCIENCES (2022)
Breast Cancer-Delivered Exosomal miRNA as Liquid Biopsy Biomarkers for Metastasis Prediction: A Focus on Translational Research with Clinical Applicability
Oana Baldasici et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
The lingering mysteries of metastatic recurrence in breast cancer
Alessandra I. Riggio et al.
BRITISH JOURNAL OF CANCER (2021)
miRNAs as biomarkers for early cancer detection and their application in the development of new diagnostic tools
Leonardo J. Galvao-Lima et al.
BIOMEDICAL ENGINEERING ONLINE (2021)
Molecular Subtypes, Metastatic Pattern and Patient Age in Breast Cancer: An Analysis of Italian Network of Cancer Registries (AIRTUM) Data
Giovanna Tagliabue et al.
JOURNAL OF CLINICAL MEDICINE (2021)
Potential value of circulatory microRNA10b gene expression and its target E-cadherin as a prognostic and metastatic prediction marker for breast cancer
Fatma Ibrahim Dwedar et al.
JOURNAL OF CLINICAL LABORATORY ANALYSIS (2021)
Direct Detection of miR-122 in Hepatotoxicity Using Dynamic Chemical Labeling Overcomes Stability and isomiR Challenges
Barbara Lopez-Longarela et al.
ANALYTICAL CHEMISTRY (2020)
Cancer-associated fibroblast heterogeneity in axillary lymph nodes drives metastases in breast cancer through complementary mechanisms
Floriane Pelon et al.
NATURE COMMUNICATIONS (2020)
Oncogenic miRNAs Identified in Tear Exosomes From Metastatic Breast Cancer Patients
Sachiko Inubushi et al.
ANTICANCER RESEARCH (2020)
MicroRNA-21 as a predictor and prognostic factor for trastuzumab therapy in human epidermal growth factor receptor 2-positive metastatic breast cancer
Marwa Badr et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2019)
A miRNA Expression Signature in Breast Tumor Tissue Is Associated with Risk of Distant Metastasis
Thomas E. Rohan et al.
CANCER RESEARCH (2019)
Potential value of circulatory microRNA122 gene expression as a prognostic and metastatic prediction marker for breast cancer
Amany A. Saleh et al.
MOLECULAR BIOLOGY REPORTS (2019)
Circulating miRNAs as a marker of metastatic disease and prognostic factor in metastatic breast cancer
Chara Papadaki et al.
Oncotarget (2019)
Circulating microRNAs miR-331 and miR-195 differentiate local luminal a from metastatic breast cancer
Peter McAnena et al.
BMC CANCER (2019)
Why Has Breast Cancer Screening Failed to Decrease the Incidence of de Novo Stage IV Disease?
Danielle R. Heller et al.
CANCERS (2019)
Emerging roles of exosomal miRNAs in breast cancer drug resistance
Hamid Najminejad et al.
IUBMB LIFE (2019)
Brain metastasis-related microRNAs in patients with advanced breast cancer
Jun Sato et al.
PLOS ONE (2019)
A novel panel of differentially-expressed microRNAs in breast cancer brain metastasis may predict patient survival
Athina Giannoudis et al.
SCIENTIFIC REPORTS (2019)
Exosomal miRNA profile as complementary tool in the diagnostic and prediction of treatment response in localized breast cancer under neoadjuvant chemotherapy
Alba Rodriguez-Martinez et al.
BREAST CANCER RESEARCH (2019)
Prognostic role of elevated mir-24-3p in breast cancer and its association with the metastatic process
Alireza Khodadadi-Jamayran et al.
Oncotarget (2018)
Overview of MicroRNA Biogenesis, Mechanisms of Actions, and Circulation
Jacob O'Brien et al.
FRONTIERS IN ENDOCRINOLOGY (2018)
The diagnostic role of miR-122 in drug-induced liver injury A systematic review and meta-analysis
Yiqi Liu et al.
MEDICINE (2018)
Breast cancer subtypes and the risk of distant metastasis at initial diagnosis: a population-based study
Weikai Xiao et al.
CANCER MANAGEMENT AND RESEARCH (2018)
Circulating microRNAs in the early prediction of disease recurrence in primary breast cancer
Chara Papadaki et al.
BREAST CANCER RESEARCH (2018)
Prognostic outcomes in advanced breast cancer: the metastasis-free interval is important
Tiansheng Shen et al.
HUMAN PATHOLOGY (2017)
Breast cancer subtypes predict the preferential site of distant metastases: a SEER based study
Qi Wu et al.
ONCOTARGET (2017)
miR-629-3p may serve as a novel biomarker and potential therapeutic target for lung metastases of triple-negative breast cancer
Jin Wang et al.
BREAST CANCER RESEARCH (2017)
MicroRNA-421 inhibits breast cancer metastasis by targeting metastasis associated 1
Yongqin Pan et al.
BIOMEDICINE & PHARMACOTHERAPY (2016)
A novel gene expression signature for bone metastasis in breast carcinomas
C. Dilara Savci-Heijink et al.
BREAST CANCER RESEARCH AND TREATMENT (2016)
Circulating miRNAs with prognostic value in metastatic breast cancer and for early detection of metastasis
Dharanija Madhavan et al.
CARCINOGENESIS (2016)
Identification of a circulating MicroRNA signature to distinguish recurrence in breast cancer patients
Dezheng Huo et al.
ONCOTARGET (2016)
Association of miR-1266 with Recurrence/Metastasis Potential in Estrogen Receptor Positive Breast Cancer Patients
Elif Demirdogen Sevinc et al.
Asian Pacific Journal of Cancer Prevention (2015)
Prognosis of metastatic breast cancer: are there differences between patients with de novo and recurrent metastatic breast cancer?
D. J. A. Lobbezoo et al.
BRITISH JOURNAL OF CANCER (2015)
Abnormal expression of miR-1 in breast carcinoma as a potent prognostic factor
Hiroyuki Minemura et al.
CANCER SCIENCE (2015)
miR-20b is up-regulated in brain metastases from primary breast cancers
Aamir Ahmad et al.
ONCOTARGET (2015)
Quantitative Measurement of Serum MicroRNA-21 Expression in Relation to Breast Cancer Metastasis in Chinese Females
Guinian Wang et al.
ANNALS OF LABORATORY MEDICINE (2015)
Prognostic Significance of Metastasis-Related MicroRNAs in Early Breast Cancer Patients with a Long Follow-up
Athina Markou et al.
CLINICAL CHEMISTRY (2014)
miR148b is a major coordinator of breast cancer progression in a relapse-associated microRNA signature by targeting ITGA5, ROCK1, PIK3CA, NRAS, and CSF1
Daniela Cimino et al.
FASEB JOURNAL (2013)
The miRNA-200 family and miRNA-9 exhibit differential expression in primary versus corresponding metastatic tissue in breast cancer
Karina H. Gravgaard et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
De novo sequencing of circulating miRNAs identifies novel markers predicting clinical outcome of locally advanced breast cancer
Xiwei Wu et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2012)
Direct Serum Assay for MicroRNA-21 Concentrations in Early and Advanced Breast Cancer
Sota Asaga et al.
CLINICAL CHEMISTRY (2011)
Survival differences among women with de novo stage IV and relapsed breast cancer
S. Dawood et al.
ANNALS OF ONCOLOGY (2010)
Metastatic Behavior of Breast Cancer Subtypes
Hagen Kennecke et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Circulating microRNAs as blood-based markers for patients with primary and metastatic breast cancer
Carina Roth et al.
BREAST CANCER RESEARCH (2010)
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
Alessandro Liberati et al.
PLOS MEDICINE (2009)
Quantifying heterogeneity in a meta-analysis
JPT Higgins et al.
STATISTICS IN MEDICINE (2002)
Share Paper
